|
1
|
WHO Classification of Tumours Editorial
Board (ed.): Female genital tumours: WHO Classification of Tumours
(Medicine). Vol 4. 5th edition. International Agency for Research
on Cancer, Lyon France, 2020.
|
|
2
|
Steeper TA and Rosai J: Aggressive
angiomyxoma of the female pelvis and perineum. Report of nine cases
of a distinctive type of gynecologic soft-tissue neoplasm. Am J
Surg Pathol. 7:463–475. 1983.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Smith HO, Worrell RV, Smith AY, Dorin MH,
Rosenberg RD and Bartow SA: Aggressive angiomyxoma of the female
pelvis and perineum: Review of the literature. Gynecol Oncol.
42:79–85. 1991.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chapel DB, Cipriani NA and Bennett JA:
Mesenchymal lesions of the vulva. Semin Diagn Pathol. 38:85–98.
2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Harkness R and McCluggage WG: HMGA2 is a
useful marker of vulvovaginal aggressive angiomyxoma but may be
positive in other mesenchymal lesions at this site. Int J Gynecol
Pathol. 40:185–189. 2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chan YM, Hon E, Ngai SW, Ng TY and Wong
LC: Aggressive angiomyxoma in females: Is radical resection the
only option? Acta Obstet Gynecol Scand. 79:216–220. 2000.PubMed/NCBI
|
|
7
|
Fucà G, Hindi N, Ray-Coquard I, Colia V,
Dei Tos AP, Martin-Broto J, Brahmi M, Collini P, Lorusso D,
Raspagliesi F, et al: Treatment outcomes and sensitivity to hormone
therapy of aggressive angiomyxoma: A multicenter, International,
retrospective study. Oncologist. 24:e536–e541. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Dahiya K, Jain S, Duhan N, Nanda S and
Kundu P: Aggressive angiomyxoma of vulva and vagina: A series of
three cases and review of literature. Arch Gynecol Obstet.
283:1145–1148. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lourenço C, Oliveira N, Ramos F, Ferreira
I and Oliveira M: Aggressive angiomyxoma of the vagina: A case
report. Rev Bras Ginecol Obstet. 35:575–582. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zou R, Xu H, Shi Y, Wang J, Wang S and Zhu
L: Retrospective analysis of clinicopathological features and
prognosis for aggressive angiomyxoma of 27 cases in a tertiary
center: A 14-year survey and related literature review. Arch
Gynecol Obstet. 302:219–229. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Fetsch JF, Laskin WB, Lefkowitz M,
Kindblom LG and Meis-Kindblom JM: Aggressive angiomyxoma: A
clinicopathologic study of 29 female patients. Cancer. 78:79–90.
1996.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Orfanelli T, Kim CS, Vitez SF, Van Gurp J
and Misra N: A case report of aggressive angiomyxoma in pregnancy:
Do hormones play a role? Case Rep Obstet Gynecol.
2016(6810368)2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kooy J, Carlson V, Šačiragić L, Sawhney S
and Nelson G: A case series of aggressive angiomyxoma: Using
morphologic type and hormonal modification to tailor treatment.
Gynecol Oncol Rep. 36(100765)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Blandamura S, Cruz J, Faure Vergara L,
Machado Puerto I and Ninfo V: Aggressive angiomyxoma: A second case
of metastasis with patient's death. Hum Pathol. 34:1072–1074.
2003.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Dellapasqua S and Colleoni M: Letrozole.
Expert Opin Drug Metab Toxicol. 6:251–259. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mizoguchi C, Matsumoto H, Nasu K, Arakane
M, Kai K and Narahara H: Intravenous leiomyomatosis treated with
radical hysterectomy and adjuvant aromatase inhibitor therapy. J
Obstet Gynaecol Res. 42:1405–1408. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nasu K, Tsuno A, Takai N and Narahara H: A
case of benign metastasizing leiomyoma treated by surgical
castration followed by an aromatase inhibitor, anastrozole. Arch
Gynecol Obstet. 279:255–257. 2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
El-Saghir NS, El-Hajj II, Makarem JA and
Otrock ZK: Combined ovarian ablation and aromatase inhibition as
first-line therapy for hormone receptor-positive metastatic breast
cancer in premenopausal women: Report of three cases. Anticancer
Drugs. 17:999–1002. 2006.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Metcalfe K, Lynch HT, Foulkes WD, Tung N,
Kim-Sing C, Olopade OI, Eisen A, Rosen B, Snyder C, Gershman S, et
al: Effect of oophorectomy on survival after breast cancer in BRCA1
and BRCA2 mutation carriers. JAMA Oncol. 1:306–313. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Finch AP, Lubinski J, Møller P, Singer CF,
Karlan B, Senter L, Rosen B, Maehle L, Ghadirian P, Cybulski C, et
al: Impact of oophorectomy on cancer incidence and mortality in
women with a BRCA1 or BRCA2 mutation. J Clin Oncol. 32:1547–1553.
2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chen D, Reierstad S, Lu M, Lin Z, Ishikawa
H and Bulun SE: Regulation of breast cancer-associated aromatase
promoters. Cancer Lett. 273:15–27. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sirasagi A and Arakeri S: Deep aggressive
angiomyxoma of pelvic soft tissue: A rare case report. J Obstet
Gynaecol India. 64:438–439. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Beuran M, Ciubotaru C, Runcanu A, Enache V
and Negoi I: Surgical resection of retroperitoneal aggressive
angiomyxoma: Case report and review of the literature. Cureus.
9(e1485)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Song M, Glasgow M, Murugan P and Rivard C:
Aggressive angiomyxoma of the vulva and bladder. Obstet Gynecol.
130:885–888. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gaurav A, Gill P, Khoiwal K, Chowdhuri S,
Kapoor D and Chaturvedi J: Aggressive angiomyxoma of the vulva-a
rare entity: Case report and review of literature. Int J Reprod
Contracept Obstet Gynecol. 9:2605–2609. 2020.
|
|
26
|
Lee MY, da Silva B, Ramirez DC and Maki
RG: Novel HMGA2-YAP1 fusion gene in aggressive angiomyxoma. BMJ
Case Rep. 12(e227475)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Giles DL, Liu PT, Lidner TK and Magtibay
PM: Treatment of aggressive angiomyxoma with aromatase inhibitor
prior to surgical resection. Int J Gynecol Cancer. 18:375–379.
2008.PubMed/NCBI View Article : Google Scholar
|
